Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
2(10%)
Results Posted
18%(2 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_2
3
14%
Ph early_phase_1
1
5%
Ph not_applicable
15
71%
Ph phase_3
1
5%
Ph phase_4
1
5%

Phase Distribution

1

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution21 total trials
Early Phase 1First-in-human
1(4.8%)
Phase 2Efficacy & side effects
3(14.3%)
Phase 3Large-scale testing
1(4.8%)
Phase 4Post-market surveillance
1(4.8%)
N/ANon-phased studies
15(71.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

2

trials recruiting

Total Trials

21

all time

Status Distribution
Active(3)
Completed(11)
Terminated(2)
Other(5)

Detailed Status

Completed11
unknown5
Withdrawn1
Not yet recruiting1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
2
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (4.8%)
Phase 23 (14.3%)
Phase 31 (4.8%)
Phase 41 (4.8%)
N/A15 (71.4%)

Trials by Status

withdrawn15%
not_yet_recruiting15%
active_not_recruiting15%
recruiting15%
terminated15%
unknown524%
completed1152%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT07063056Not Applicable

Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation

Recruiting
NCT07684391Not Applicable

Effect of Oral Astaxanthin Formula on Pulmonary Rehabilitation in Patients With COPD

Not Yet Recruiting
NCT07630870Not Applicable

The Effects of Astaxanthin on Physiological Anti-fatigue and Sports Performance: an Integrated Study From the Application of Laboratory Human Sports Platform to Simulated Competitions

Active Not Recruiting
NCT06460181Phase 4

Impact of Astaxanthin on Cognition in Recreationally Active Females

Completed
NCT06429059Phase 2

ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments

Completed
NCT05138549Phase 2

Astaxanthin for Management of Inflammation in Knee Osteoarthritis

Terminated
NCT05015374Not Applicable

Effect of Astaxanthin on the Patients With Alzheimer Disease

Completed
NCT03310359Not Applicable

Clinical Trial of Anti-oxidant Astaxanthin in Insulin-resistant Subjects

Completed
NCT05409092Not Applicable

Astaxanthin, Exercise Inflammation, Skin Health

Completed
NCT05376501Not Applicable

A Study to Evaluate the Effect of Astaxanthin in Healthy Participants

Completed
NCT03664466Not Applicable

Astaxanthin Effects on Osteoarthritis Associated Pain and Inflammatory Indicators

Withdrawn
NCT05282355Not Applicable

Astaxanthin Reduces Exercising Heart Rate.

Completed
NCT04249128Phase 3

Nourishing Hair, Skin & Nails Supplement Study (Derm Aid)

Completed
NCT04689984Phase 2

The Benefits of Astaxanthin as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient

Unknown
NCT03443882Early Phase 1

Bioavailability of Astaxanthin Formulations

Unknown
NCT03807050Not Applicable

Safety and Pharmacokinetics of Phaffia Rhodozyma Astaxanthin

Completed
NCT02343497Not Applicable

Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Mild Dyslipidaemia

Completed
NCT02373111Not Applicable

Effects of Isoflavone Combined With Astaxanthin on Skin Aging

Completed
NCT02088242Not Applicable

Physiological and Molecular Influences of Astaxanthin Supplementation on Heat Strain in Humans

Unknown
NCT01241877Not Applicable

Astaxanthin Supplementation in Cyclists

Unknown

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
21